Diabetes treatment is constantly evolving, with new therapeutic options appearing to improve patient outcomes. Recent studies have focused on GLP-1 and GIP receptor agonists, a group of drugs that mimic the actions of https://donnamfzk435401.ltfblog.com/37627961/emerging-glp-1-and-gip-receptor-agonists-a-new-era-in-diabetes-treatment